Friday 6 November 2026 Export RGC’s income statement to Excel — free account

Regencell Bioscience Holdings Limited

RGC Healthcare Drug Manufacturers Specialty & Generic

Dividend growth 3 yrs

5.29 0.02 +0.38%

Follow RGC

Alert me

Market cap: $2.6B
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview

	Older periods	Jun '24	Jun '25	Dec '25	Jun '26
ROE Full definition →	+8 more TTM periods Free account	0.00%	0.00%	0.00%	0.00%
ROA Full definition →		0.00%	0.00%	0.00%	0.00%
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Free Cash Flow per Share Full definition →		0.00	0.00	0.00	—
Free Cash Flow Full definition →		(15.81)	(18.31)	(14.67)	—
Capital Expenditures Full definition →		(0.81)	(0.97)	—	—
Other line items
Cash ROIC Full definition →		(97.72%)	(187.68%)	(410.18%)	0.00%
Operating CF/Net income Full definition →		0.00	0.00	0.00	—
Depreciation/Fixed assets Full definition →		0.84	0.77	0.00	0.00
Capex/Depreciation Full definition →		(1.05)	(1.17)	—	—
Operating CF per Share Full definition →		0.00	0.00	0.00	—
Capex per Share Full definition →		0.00	0.00	—	—
Capex to Sales Full definition →		0.00	0.00	—	—

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026